ABOUT US
WHAT WE DO
CLINICAL TRIALS AND STUDIES
NEWS
CONTACT
More
AT MEDSIR WE ARE DEDICATED TO OFFER THE MOST RELEVANT NEWS ON THE LATEST ADVANCEMENTS IN ONCOLOGY CLINICAL RESEARCH. FIND OUT THE LATEST NEWS ON ONCOLOGY RESEARCH, REGULATORY APPROVALS, EVENTS, SCIENTIFIC CONFERENCES AND MUCH MORE!
PHERGain-2: Approved in 5 countries
HER2 Breast Cancer: Types and Treatments
Spotlight: PHERGain-2 HER2+ early breast cancer trial
Dr. José Manuel Pérez Discusses Advances in Treatment Options for HER2+ Breast Cancer
DESTINY-BREAST03 results establish T-DXd as the standard of care for 2L metastatic breast cancer
DEBBRAH Study (breast)
PHERGain Study (breast)
